Skip to main content

. 1964 Oct 10;2(5414):915–917. doi: 10.1136/bmj.2.5414.915

Laevadosin in Treatment of the Duchenne Type of Muscular Dystrophy: Preliminary Results of a Double-blind Controlled Trial

J M S Pearce, S S Gubbay, Jennifer Hardy, R J T Pennington, D J Newell, John N Walton

PMCID: PMC1816923 PMID: 14185658

915

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BARWICK D. D., NEWELL D. J., WALTON J. N. Methandrostenolone and nandrolone decanoate in muscular dystrophy; a controlled trial. Neurology. 1963 Jan;13:12–23. doi: 10.1212/wnl.13.1.12. [DOI] [PubMed] [Google Scholar]
BEKENY G., KRAFT F., LANG S. Die Anwendung von Methylandrostendiol (Neosteron) in der Behandlung der Dystrophia musculorum progressiva. Psychiatr Neurol (Basel) 1959 Apr;137(4):193–208. [PubMed] [Google Scholar]
DE TONI E., Jr [The effects of anabolizing steroids on creatine metabolism in progressive muscular dystrophy]. Clin Pediatr (Bologna) 1959 Jun;41:441–445. [PubMed] [Google Scholar]
GUEST K. E., MCLAY W. D. TREATMENT OF MUSCULAR DYSTROPHY WITH A NUCLEOTIDES- NUCLEOSIDES COMBINATION. Br J Clin Pract. 1964 Jul;18:395–400. [PubMed] [Google Scholar]
HANTSCHMANN N., MATZELT D., MERTENS H. G., NOWAKOWSKI H. [On the treatment of muscular diseases by anabolic steroids. I. Metabolic studies]. Dtsch Med Wochenschr. 1962 Dec 21;87:2619–2626. doi: 10.1055/s-0028-1114139. [DOI] [PubMed] [Google Scholar]
THOMSON W. H., GUEST K. E. A trial of therapy by nucleosides and nucleotides in muscular dystrophy. J Neurol Neurosurg Psychiatry. 1963 Apr;26:111–122. doi: 10.1136/jnnp.26.2.111. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES